ASX · SDI.AX
SDI Limited
A$1.40+A$0.00 (+0.14%)
SDI Limited’s quoted price sits in the upper half of its reported 52-week range, 0.21% below the high.
Loading market information…
ASX · EZZ.AX · AUD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 04:44 AM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
EZZ Life Science Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 88.62% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
EZZ Life Science Holdings Limited’s forward annual dividend is A$0.04 per share, paid semi-annual. The forward yield is 13.11% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
EZZ Life Science Holdings Limited’s next earnings report is currently expected on Mar 1, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow EZZ Life Science Holdings Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
EZZ Life Science Holdings Limited, an Australian company, specializes in offering a range of skincare and consumer health products, with its market presence extending across Australia, New Zealand, Mainland China, and other international territories. The company's operations are divided into two distinct segments: 'Brought in Lines' and 'Company Owned products.' EZZ is actively involved in the wholesale supply of its EAORON-branded skincare portfolio, distributing it to pharmacies, major supermarkets, specialist retailers, and general grocery stores. Furthermore, the company designs, develops, manufactures, and markets a comprehensive selection of consumer health products under its own EZZ brand. This extensive offering includes vitamins, dietary supplements, sports nutrition, weight management and wellbeing solutions, traditional herbal remedies, and paediatric lines. These EZZ-branded items are sold directly to consumers via its e-commerce platforms and various retail stores, notably Tmall Global. Founded in 2015, EZZ Life Science Holdings Limited maintains its corporate headquarters in Silverwater, Australia.
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:03 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| A$0.03 |
| A$15.13M |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$1.40+A$0.00 (+0.14%)
SDI Limited’s quoted price sits in the upper half of its reported 52-week range, 0.21% below the high.
A$0.04-A$0.00 (-2.33%)
Actinogen Medical Limited’s quoted price sits in the lower half of its reported 52-week range, 41.67% below the high.
A$2.74A$0.00 (0.0%)
Vita Life Sciences Limited’s quoted price sits in the upper half of its reported 52-week range, 5.52% below the high.
A$0.36+A$0.03 (+9.09%)
Recce Pharmaceuticals Ltd’s quoted price sits in the lower half of its reported 52-week range, 50.68% below the high.
A$0.29-A$0.04 (-10.77%)
Island Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 53.97% below the high.
A$0.36A$0.00 (0.0%)
Biome Australia Limited’s quoted price sits in the upper half of its reported 52-week range, 26.53% below the high.
A$0.05+A$0.00 (+3.92%)
Arovella Therapeutics Limited’s quoted price sits in the lower half of its reported 52-week range, 47.0% below the high.
A$0.27+A$0.01 (+1.92%)
Alterity Therapeutics Limited’s quoted price sits in the lower half of its reported 52-week range, 66.24% below the high.
